Table 1.

Characteristics of the patients who were subsequently diagnosed with prostate cancer

Men age 60 at time of blood draw, n (%)Men ages 51-56 at time of blood draw, n (%)
PSA ≥3 ng/mL at baseline, n = 57PSA <3 ng/mL at baseline, n = 75PSA ≥3 ng/mL at baseline, n = 116PSA <3 ng/mL at baseline, n = 379
Clinical stage
    T0/T15 (9)26 (35)25 (22)135 (36)
    T226 (46)21 (28)34 (29)129 (34)
    T3/T421 (37)15 (20)49 (42)97 (26)
    Unknown5 (9)13 (17)8 (7)18 (5)
Biopsy grade
    Gleason ≤6 or WHO 121 (37)31 (41)43 (37)203 (54)
    Gleason 7 or WHO 220 (35)16 (21)40 (34)106 (28)
    Gleason ≥8 or WHO 311 (19)15 (20)23 (20)51 (13)
    Unknown5 (9)13 (17)10 (9)19 (5)
Died49 (86)44 (59)0 (0)0 (0)
Alive at last follow-up8 (14)31 (41)116 (100)379 (100)